CALGARY, AB--(Marketwired - September 24, 2015) - FPS PHARMA INC. (the "Company") (CSE: FPS.U) received an email from the Canadian Securities Exchange ("CSE") yesterday afternoon that contained an attachment which was a letter from a New Jersey based attorney representing a former Director, President and CEO of Florida Pharmacy Solutions, Inc. ("FPS"), a wholly owned subsidiary of the Company. A copy of this same letter was also sent to the Alberta Securities Commission.

James Wesley Moss was removed as a Director, President and CEO of FPS on September 23, 2015. Mr. Moss is currently in the process of being removed as a Director of FPS Pharma Inc.

The Company believes that the allegations asserted in this letter are wholly inaccurate and false and have asked that this letter be retracted. Accordingly, the Company intends to vigorously defend any further actions taken by Mr. Moss.

"James R. Brown"
James R. Brown
Chairman, President & CEO

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release.

Contact Information:

For further information please contact:
FPS Pharma Inc.
James R. Brown
Chairman, President & CEO